When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Eosinophilic esophagitis

Last reviewed: 5 Oct 2024
Last updated: 22 Mar 2024

Summary

Definition

History and exam

Key diagnostic factors

  • dysphagia
  • food avoidance and modification behaviors
Full details

Other diagnostic factors

  • heartburn
  • chest discomfort
  • nausea/vomiting
  • regurgitation
  • abdominal pain
  • failure to thrive
  • irritability
Full details

Risk factors

  • family history of EoE
  • male sex
  • atopic disease
  • children and younger adults
  • white ancestry
Full details

Diagnostic tests

1st tests to order

  • esophagogastroduodenoscopy
  • esophageal biopsy
  • CBC with differential
Full details

Emerging tests

  • transnasal endoscopy
  • esophageal string test
  • cytosponge
  • Esophageal physiological testing
  • EoE diagnostic panel

Treatment algorithm

ACUTE

at initial diagnosis

ONGOING

response to initial therapy

nonresponse or relapse

Contributors

Authors

Jenny Epstein, MB ChB MRCPCH PhD

Consultant Paediatric Gastroenterologist

Chelsea and Westminster Hospital

London

UK

Disclosures

JE is a member of the advisory board for Dr Falk Pharma, manufacturer of Jorveza, a new formulation of budesonide licensed for adults with eosinophilic esophagitis (EoE), and Nurtricia for infant functional bowel disorders. She has received honoraria from Dr Falk Pharma to speak on EoE and has been sponsored by Dr Falk Pharma, Abbvie and Nutricia to attend national and international meetings. JE is a member of BSPGHAN IBD working group, medical advisor to CICRA and Coeliac UK, member of CCUK IBD working group, member of BSG EoE Guideline development group, member of NICE Guideline update committee for Crohn disease and ulcerative colitis, member of NICE Diagnostics, and sits on the NICE advisory committee for personalized treatment in Crohn disease.

Acknowledgements

Dr Jenny Epstein wishes to gratefully acknowledge Dr Evan S. Dellon, the previous contributor to this topic.

Disclosures

ESD is an author of a number of references cited in this topic.

Peer reviewers

David Katzka, MD

Professor of Medicine

Mayo Clinic

Rochester

MN

Disclosures

DK has served on advisory boards (Adare, Receptos) and received research funding (Covidien).

Alexandra Papadopoulou, MD

Honorary Professor

Chief of the Division of Gastroenterology and Hepatology

First Department of Pediatrics

University of Athens

Agia Sofia Children’s Hospital

Athens

Greece

Disclosures

AP has received speaker’s honorariums from Nestle and Nutricia; research grants from Biogaia/Nutricia/Abbvie; consultant’s fee from Receptos.

  • Eosinophilic esophagitis images
  • Differentials

    • Gastroesophageal reflux disease (GERD)
    • Eosinophilic gastroenteritis
    • Achalasia
    More Differentials
  • Guidelines

    • Joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults
    • Practice guideline: adverse events associated with EGD and EGD-related techniques
    More Guidelines
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer